JOIN LABCORP AT

Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Nov. 1-5, 2023 | San Diego, California, or Virtual
Booth 424
Robust Portfolio of Precision Oncology Solutions

From discovery to clinical trial assay support and companion diagnostic development and commercialization, Labcorp offers comprehensive oncology solutions for immunotherapy development including syngeneic mouse tumor models, immune profiling NGS, TCR-β repertoire, custom bioinformatics and more. 

Visit with one of our dedicated team members onsite to learn more about our tailored services, broad portfolio of solid tissue and liquid biopsy NGS to help pharmaceutical and biotech companies accelerate innovation, unlock value and bring the promise of precision medicine to more patients. 
Spotlight on science

Visit our posters at SITC
Friday, Nov. 3, 2023
Location: Exhibit Halls A and B1 – San Diego Convention Center


#175 - Metastatic triple negative breast cancer has distinct tumor immune landscape - R.J. Seager

#183 - Comprehensive genomic and immune profiling (CGIP) reveals a distinct genomic and immune gene expression profile for younger patients with non-small cell lung cancer (NSCLC) - Zachary Wallen

#513 - Comprehensive genomic and immune profiling of ALK fusion-positive and negative lung adenocarcinomas - Kyle Strickland

#1455 - Characterization of gene expression signatures of tumor immunogenicity and cellular proliferation from murine cancer models grown in vitro and in vivo - Kyle Strickland

#1499 - Molecular and immune profiling of lobular-enriched versus non-lobular invasive breast cancers - Kyle Strickland

Saturday, Nov. 4, 2023 
Location: Exhibit Halls A and B1 – San Diego Convention Center


#176 - Immune microenvironment of primary versus metastatic melanoma of the brain - Maria-Fernanda (Mafe) Senosain

#184 - Distinct immunotherapy immune response phenotypes in non-small cell lung cancer present with unique genomic alteration profiles - Zachary Wallen